cetraxate has been researched along with geranylgeranylacetone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukuchi, S | 1 |
Kawahara, T; Kihara, Y; Maga, T; Mikami, Y; Mizuno, M; Okada, H; Tanaka, S; Tsuji, T; Yoshinaga, F; Yunoki, N | 1 |
Arakawa, T; Sugimori, S; Watanabe, T | 1 |
1 review(s) available for cetraxate and geranylgeranylacetone
Article | Year |
---|---|
[Side effects of gastric muco-protective agents].
Topics: Adjuvants, Pharmaceutic; Alanine; Alprostadil; Aluminum; Anti-Ulcer Agents; Diterpenes; Drug Interactions; Gastric Acid; Gastric Emptying; Humans; Hydrogen-Ion Concentration; Misoprostol; Quinolones; Sulpiride; Tranexamic Acid | 2007 |
2 other study(ies) available for cetraxate and geranylgeranylacetone
Article | Year |
---|---|
[Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; administration of synergistic drugs for protective factors in peptic ulcer--criteria of drug selection according to clinical symptoms and administration methods].
Topics: Anti-Ulcer Agents; Cyclohexanecarboxylic Acids; Diterpenes; Gefarnate; Humans; Peptic Ulcer; Recurrence; Sucralfate; Tranexamic Acid | 1988 |
Geranylgeranylacetone and cetraxate hydrochloride increase UDP-galactosyltransferase activity in rat gastric mucosa.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Diterpenes; Galactosyltransferases; Gastric Mucosa; Male; Prostaglandins; Rats; Rats, Sprague-Dawley; Tranexamic Acid | 1997 |